Skip to main content

Maetzold Derek J's Form 4 filing

Castle Biosciences Inc (CSTL) · filed Oct 12, 2022

Accession no.
0001447362-22-000160
Filed
Oct 12, 2022
Trade date
Oct 10-11, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 30 non-derivative transactions. Open-market sales total $203.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Maetzold Derek JCIK 0001239501Director, Officer (Pres. & Chief Exec. Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 10, 2022Common StockSSaleDisposed−2,659$24.45F2−$65,012.55301,230Direct
Oct 10, 2022Common StockSSaleDisposed−1,300$24.45F2−$31,785135,153Indirect
Oct 10, 2022Common StockSSaleDisposed−1,214$24.45F2−$29,682.3123,260Indirect
Oct 10, 2022Common StockSSaleDisposed−259$24.45F2−$6,332.5527,464Indirect
Oct 10, 2022Common StockSSaleDisposed−260$24.45F2−$6,35727,461Indirect
Oct 10, 2022Common StockSSaleDisposed−260$24.45F2−$6,35727,461Indirect
Oct 10, 2022Common StockSSaleDisposed−262$24.45F2−$6,405.927,457Indirect
Oct 10, 2022Common StockSSaleDisposed−86$25.23F9−$2,169.78301,144Direct
Oct 10, 2022Common StockSSaleDisposed−42$25.23F9−$1,059.66135,111Indirect
Oct 10, 2022Common StockSSaleDisposed−39$25.23F9−$983.97123,221Indirect
Oct 10, 2022Common StockSSaleDisposed−8$25.23F9−$201.8427,456Indirect
Oct 10, 2022Common StockSSaleDisposed−8$25.23F9−$201.8427,453Indirect
Oct 10, 2022Common StockSSaleDisposed−8$25.23F9−$201.8427,453Indirect
Oct 10, 2022Common StockSSaleDisposed−9$25.23F9−$227.0727,448Indirect
Oct 10, 2022Common StockSSaleDisposed−43$26.26−$1,129.18301,101Direct
Oct 10, 2022Common StockSSaleDisposed−21$26.26−$551.46135,090Indirect
Oct 10, 2022Common StockSSaleDisposed−20$26.26−$525.2123,201Indirect
Oct 10, 2022Common StockSSaleDisposed−4$26.26−$105.0427,452Indirect
Oct 10, 2022Common StockSSaleDisposed−4$26.26−$105.0427,449Indirect
Oct 10, 2022Common StockSSaleDisposed−4$26.26−$105.0427,449Indirect
Oct 10, 2022Common StockSSaleDisposed−4$26.26−$105.0427,444Indirect
Oct 11, 2022Common StockSSaleDisposed−385$22.95F10−$8,835.75300,716Direct
Oct 11, 2022Common StockSSaleDisposed−189$22.95F10−$4,337.55134,901Indirect
Oct 11, 2022Common StockSSaleDisposed−176$22.95F10−$4,039.2123,025Indirect
Oct 11, 2022Common StockSSaleDisposed−38$22.95F10−$872.127,414Indirect
Oct 11, 2022Common StockSSaleDisposed−38$22.95F10−$872.127,411Indirect
Oct 11, 2022Common StockSSaleDisposed−38$22.95F10−$872.127,411Indirect
Oct 11, 2022Common StockSSaleDisposed−36$22.95F10−$826.227,408Indirect
Oct 11, 2022Common StockSSaleDisposed−661$24.05F11−$15,897.05300,055Direct
Oct 11, 2022Common StockSSaleDisposed−323$24.05F11−$7,768.15134,578Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $24.03 to $24.97, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $25.06 to $25.40, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $22.60 to $23.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

F11

This transaction was executed in multiple trades at prices ranging from $23.63 to $24.30, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 2 transactions in Table I.

Remarks

This Form 4 is the first of two Form 4s being filed by the Reporting Person relating to the same event. The Form 4 has been split into two filings to cover all 35 individual transactions that occurred on the same Transaction Date, because the SEC's EDGAR filing system limits a single Form 4 to a maximum of 30 separate transactions.

Read the full filing on SEC EDGAR (opens in a new tab)